Impact of stage 3B chronic kidney disease on thrombosis and bleeding outcomes after orthopedic surgery in patients treated with desirudin or enoxaparin: insights from a randomized trial.

Find People
Find Everything
About This Site
Edit My Profile
Export RDF
Login to Profiles

Impact of stage 3B chronic kidney disease on thrombosis and bleeding outcomes after orthopedic surgery in patients treated with desirudin or enoxaparin: insights from a randomized trial.

Shorr AF, Eriksson BI, Jaffer AK, Smith J. Impact of stage 3B chronic kidney disease on thrombosis and bleeding outcomes after orthopedic surgery in patients treated with desirudin or enoxaparin: insights from a randomized trial. J Thromb Haemost. 2012 Aug; 10(8):1515-20.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Anticoagulants
Arthroplasty, Replacement, Hip
Drug Administration Schedule
Enoxaparin
Female
Hirudins
Humans
Injections, Subcutaneous
Logistic Models
Male
Middle Aged
Multicenter Studies as Topic
Odds Ratio
Patient Selection
Postoperative Hemorrhage
Randomized Controlled Trials as Topic
Recombinant Proteins
Renal Insufficiency, Chronic
Retrospective Studies
Risk Assessment
Risk Factors
Severity of Illness Index
Thrombosis
Time Factors
Treatment Outcome
Young Adult

authors with profiles

Amir Jaffer